Levobunolol Hydrochloride

Welcome to Dwaey, specifically on Levobunolol Hydrochloride page.
This medicine contains important and useful components, as it consists of
Levobunolol Hydrochloride is available in the market in concentration.

Generic Name of Levobunolol Hydrochloride - Learn More

Levobunolol Hydrochloride

Levobunolol Hydrochloride Precaution - What You Need to Know

Levobunolol hydrochloride is a non-selective beta-blocker used primarily in the treatment of elevated intraocular pressure (IOP) in conditions like glaucoma and ocular hypertension. When prescribing levobunolol, there are important precautions to consider. It should be used with caution in patients with a history of asthma, chronic obstructive pulmonary disease (COPD), or other respiratory conditions because beta-blockers can exacerbate bronchoconstriction due to their non-selective action. For individuals with severe chronic obstructive pulmonary disease or asthma, a more selective beta-1 blocker may be preferred.

Levobunolol should also be avoided in patients with bradycardia, heart block, hypotension, or those with a history of heart failure, as beta-blockers can worsen these conditions by reducing heart rate and contractility. Regular monitoring of heart rate and blood pressure is essential during treatment. Additionally, patients with a history of diabetes should use levobunolol with caution, as beta-blockers can mask the symptoms of hypoglycemia, potentially leading to delayed detection and treatment of low blood sugar.

For pregnant and breastfeeding women, levobunolol should be used only if the potential benefit justifies the potential risk to the fetus or infant. It is classified as a pregnancy category C drug, meaning there is limited evidence on its safety during pregnancy. As levobunolol can be excreted in breast milk, breastfeeding mothers should weigh the potential risks before use.

Levobunolol Hydrochloride Indication - Uses and Benefits

Levobunolol hydrochloride is primarily indicated for the reduction of intraocular pressure (IOP) in individuals with glaucoma or ocular hypertension. Elevated IOP is a major risk factor for optic nerve damage and glaucoma, which can lead to vision loss. By reducing IOP, levobunolol helps to decrease the risk of progressive damage to the optic nerve and preserve vision in these patients. Levobunolol is typically used in conjunction with other treatments when monotherapy is insufficient to control IOP.

Levobunolol is used as an eye drop, and it works by decreasing the production of aqueous humor in the eye, thereby reducing the overall intraocular pressure. It has been found to be effective in both open-angle glaucoma and ocular hypertension.

Off-label uses of levobunolol may include managing elevated IOP in patients undergoing treatment for other ocular diseases, although its primary approved indication remains for glaucoma and ocular hypertension.

Levobunolol Hydrochloride Contraindications - Important Warnings

Levobunolol hydrochloride is contraindicated in patients with a history of hypersensitivity or allergic reactions to levobunolol or any of its components. It should not be used in individuals with conditions that are contraindications for beta-blockers, such as severe bradycardia, heart block greater than first degree, or cardiogenic shock, as these conditions can be worsened by the beta-blocking effects of levobunolol.

Additionally, it is contraindicated in patients with bronchial asthma or a history of asthma, as non-selective beta-blockers like levobunolol can provoke bronchospasm by blocking beta-2 adrenergic receptors in the lungs, leading to difficulty breathing and exacerbation of respiratory symptoms.

Patients with severe chronic obstructive pulmonary disease (COPD), as well as those with untreated pheochromocytoma, should not use levobunolol. If there is a need to initiate therapy in patients with controlled pheochromocytoma, beta-blockers should be used with caution, under strict medical supervision, and with appropriate alpha-blockade therapy to avoid hypertensive crises.

Levonbunolol is contraindicated in cases of significant heart failure or any condition that causes severe hypotension or decreased blood circulation, as it may worsen these conditions.

Levobunolol Hydrochloride Side Effects - What to Expect

Common side effects of levobunolol are generally mild and localized to the eyes. These may include eye irritation, stinging, burning, or dryness immediately after instillation. Some patients may experience temporary blurred vision or redness in the eye due to irritation from the medication.

Systemic side effects are less common but may include fatigue, headache, dizziness, bradycardia (slow heart rate), and hypotension (low blood pressure). These side effects are typically more significant in patients with pre-existing cardiovascular conditions and may require dose adjustment or discontinuation of therapy.

Less common but more severe side effects may include exacerbation of respiratory issues such as bronchospasm or shortness of breath, particularly in individuals with asthma or COPD. If these occur, patients should seek immediate medical attention.

Rare but serious systemic reactions include severe bradycardia, heart block, or worsening of heart failure. In such cases, prompt medical intervention is required, and levobunolol should be discontinued.

Levobunolol Hydrochloride Pregnancy Category ID - Safety Information

3

Levobunolol Hydrochloride Mode of Action - How It Works

Levobunolol hydrochloride is a non-selective beta-adrenergic antagonist (beta-blocker) that reduces intraocular pressure (IOP) primarily by decreasing the production of aqueous humor. By blocking both beta-1 and beta-2 adrenergic receptors in the ciliary body of the eye, levobunolol inhibits the action of norepinephrine and other sympathetic mediators that increase aqueous humor production. This results in a reduction in IOP, which is critical in the management of glaucoma and ocular hypertension.

Pharmacologically, levobunolol functions by binding to beta-adrenergic receptors on the ciliary epithelium in the eye, inhibiting the secretion of aqueous humor into the anterior chamber. This leads to a decrease in intraocular pressure and, consequently, a reduction in the risk of optic nerve damage.

Unlike some other beta-blockers, levobunolol has a minimal effect on heart rate or systemic blood pressure when used topically at the ocular site, though systemic absorption can occur with prolonged use.

Levobunolol Hydrochloride Drug Interactions - What to Avoid

Levobunolol can interact with several other medications, potentially affecting its efficacy or increasing the risk of side effects. Some key interactions include:

- Other Beta-blockers: Concurrent use of levobunolol with other systemic beta-blockers can lead to additive effects, potentially causing severe bradycardia, hypotension, and heart block. Careful monitoring is required if levobunolol is prescribed alongside other beta-blockers, and in some cases, adjustment of therapy may be needed.

- Calcium Channel Blockers: Drugs such as verapamil or diltiazem, which are calcium channel blockers, can also lower heart rate and blood pressure. When used with levobunolol, there is an increased risk of severe bradycardia and hypotension. Monitoring of heart rate and blood pressure is essential in these cases.

- Antiarrhythmic Medications: When used with antiarrhythmic drugs like digoxin or amiodarone, levobunolol may enhance the effects on heart rate and rhythm, potentially increasing the risk of arrhythmias, bradycardia, or heart failure.

- Other Ophthalmic Medications: The use of other ophthalmic beta-blockers or carbonic anhydrase inhibitors in conjunction with levobunolol may have an additive effect on lowering intraocular pressure, though this can sometimes increase the risk of systemic absorption and side effects. When using multiple ocular medications, care should be taken regarding the timing of administration, and they should ideally be administered at least 5 minutes apart.

- CYP450 Inhibitors: Drugs that inhibit the CYP450 enzyme system, such as ketoconazole, can increase levobunolol concentrations by reducing its metabolism. While this interaction is less significant compared to oral beta-blockers, it may still require dose adjustments in certain patients.

- Alcohol: Alcohol can exacerbate the blood pressure-lowering effects of levobunolol, potentially leading to excessive hypotension, dizziness, or fainting. It is advisable for patients to avoid alcohol or consume it in moderation while undergoing treatment with levobunolol.

Levobunolol Hydrochloride Adult Dose - Recommended Dosage

For the treatment of elevated intraocular pressure in patients with glaucoma or ocular hypertension, the typical adult dose of levobunolol is one drop of a 0.25% or 0.5% solution in the affected eye(s) once or twice daily, depending on the severity of the condition and the individual patient’s response.

In more severe cases, the higher concentration of 0.5% may be used, typically in the morning or evening. The dose may be adjusted based on the response to treatment, but the total daily dose should not exceed two administrations per day.

If patients are using other ocular medications, they should wait at least 5 minutes between the administration of each drop to avoid any dilution or reduced efficacy of the medications.

Levobunolol Hydrochloride Child Dose - Dosage for Children

The use of levobunolol in pediatric patients has not been extensively studied, and its safety and efficacy in children under 18 years of age are not well established. Levobunolol is generally not recommended for use in children unless specifically prescribed by a pediatric ophthalmologist for managing certain forms of elevated intraocular pressure or glaucoma, and only after careful evaluation of potential risks and benefits. If used, it should be administered with close monitoring for any side effects, especially those related to cardiovascular or respiratory systems.

Levobunolol Hydrochloride Renal Dose - Dosage for Kidney Conditions

Levonbunolol is minimally systemically absorbed when used as an ocular drop, and therefore, it does not require specific dose adjustments in patients with renal impairment. However, in patients with severe renal dysfunction or those on dialysis, systemic levels may increase, and caution should be taken when using levobunolol, with close monitoring for any adverse effects.